📷 Image: Flickr (CC)
Business
USFDA Inspects Auroactive Pharma's Andhra Pradesh Manufacturing Facility
✍️ Business Standard
🗓 28 Jun 2026, 02:32 AM
👁 29
The United States Food and Drug Administration (USFDA) has conducted an inspection of Auroactive Pharma's manufacturing unit located in Andhra Pradesh.
The United States Food and Drug Administration (USFDA) has recently carried out an inspection at a manufacturing facility belonging to Auroactive Pharma. The unit is situated in the state of Andhra Pradesh, India.
This inspection by the US regulatory body is a standard procedure for pharmaceutical companies that export products to the United States. The USFDA regularly monitors manufacturing practices to ensure compliance with stringent quality and safety standards.
Further details regarding the specific outcomes or duration of the inspection have not been publicly disclosed by the company or the regulatory agency.
This inspection by the US regulatory body is a standard procedure for pharmaceutical companies that export products to the United States. The USFDA regularly monitors manufacturing practices to ensure compliance with stringent quality and safety standards.
Further details regarding the specific outcomes or duration of the inspection have not been publicly disclosed by the company or the regulatory agency.